Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print January 25, 2006.
Biol Reprod 2006, 10.1095/biolreprod.105.050419
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
74/5/959    most recent
biolreprod.105.050419v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elustondo, P.A.
Right arrow Articles by MacPhee, D.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elustondo, P.A.
Right arrow Articles by MacPhee, D.J.
Agricola
Right arrow Articles by Elustondo, P.A.
Right arrow Articles by MacPhee, D.J.
BIOLOGY OF REPRODUCTION 74, 959–968 (2006)
DOI: 10.1095/biolreprod.105.050419
© 2006 by the Society for the Study of Reproduction, Inc.


Research Article

Integrin-Linked Kinase (ILK) Is Highly Expressed in First Trimester Human Chorionic Villi and Regulates Migration of a Human Cytotrophoblast-Derived Cell Line1

P.A. Elustondo 3, G.E. Hannigan 4, I. Caniggia 5, and D.J. MacPhee 2 3

Division of Basic Medical Sciences,3 Health Sciences Centre, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada A1B 3V6 Department of Laboratory Medicine and Pathobiology,4 University of Toronto and Cancer Research Program, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X5 Program in Development and Fetal Health,5 Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada M5G 1X5

ABSTRACT

The placenta represents a critically important fetal-maternal interaction. Trophoblast migration and invasion into the uterine wall is a precisely controlled process and aberrations in these processes are implicated in diseases such as preeclampsia. Integrin-linked kinase (ILK) is a multifunctional, cytoplasmic, serine/threonine kinase that has been implicated in regulating processes such as cell proliferation, survival, migration, and invasion; yet the temporal and spatial pattern of expression of ILK in human chorionic villi and its role in early human placental development are completely unknown. We hypothesized that ILK would be expressed in trophoblast subtypes of human chorionic villi during early placental development and that it would regulate trophoblast migration. Immunoblot analysis revealed that ILK protein was highly detectable in placental tissue samples throughout gestation. In floating branches of chorionic villi, from 6 to 15 wk of gestation immunofluorescence analysis of ILK expression in placental tissue sections demonstrated that ILK was highly detectable in the cytoplasm and membranes of villous cytotrophoblast cells and in stromal mesenchyme, whereas it was barely detectable in the syncytiotrophoblast layer. In anchoring branches of villi, ILK was highly localized to plasma membranes of extravillous trophoblast cells. Transient expression of dominant negative E359K-ILK in the villous explant-derived trophoblast cell line HTR8-SVneo dramatically reduced migration into wounds compared to cells expressing wild-type ILK or empty vector. Therefore, our work has demonstrated that ILK is highly expressed in trophoblast subtypes of human chorionic villi during the first trimester of pregnancy and is a likely mediator of trophoblast migration during this period of development.

developmental biology, kinases, placenta, pregnancy, trophoblast


FOOTNOTES

1 Supported by Canadian Institutes of Health Research grant 64731, Industrial Research and Innovation Fund grant 0405-014 (Province of Newfoundland and Labrador), and Canada Foundation for Innovation New Opportunities Fund 74119.

2 Correspondence: Daniel MacPhee, Division of Basic Medical Sciences, Health Sciences Centre, Rm. 5340B, 300 Prince Philip Dr., St. John's, Newfoundland and Labrador A1B 3V6, Canada. FAX: 709 777 7010; dmacphee{at}mun.ca







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for the Study of Reproduction.